All stock lists
BIO-TECHNE Corp (NASDAQ:TECH)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
72.69+0.14 (+0.19%)
Market cap
$11.4B
Health Score
Analyst consensus
Listed since
Feb 9, 1989
Website
Insider Score
––Not scored
TECH Insider Score
Insiders here have filed 20 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
TECH analyst forecast
TECH analyst consensus
Hold1 ratings
Buy 0 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TECH 12-month price target
No published price targets in the last 12 months.
Best analysts covering TECH
- Wells Fargo100%success rate · 2 calls
- TD Cowen100%success rate · 1 call
- Citigroup67%success rate · 3 calls
- UBS0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TECH analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2026-08-13 |
| — | RBC Capital | Sector Perform | — | — | Downgraded | 2026-07-09 |
| — | Benchmark | Hold | — | — | Downgraded | 2026-06-30 |
| — | TD Cowen | Hold | — | — | Downgraded | 2026-06-30 |
| — | Citigroup | Neutral | — | — | Downgraded | 2026-06-29 |
| — | Stephens & Co. | Equal Weight | — | — | Downgraded | 2026-06-26 |
| — | William Blair | Market Perform | — | — | Downgraded | 2026-06-26 |
| — | Baird | Neutral | — | — | Reiterated | 2026-06-26 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-05-07 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-07 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-05-07 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-04-06 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-06 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-05 |
| — | UBS | Buy | — | — | Reiterated | 2026-02-05 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-02-05 |
| — | Stifel | Hold | — | — | Reiterated | 2026-02-05 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-02-05 |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2026-01-05 |
| — | Argus Research | Buy | — | — | Reiterated | 2025-11-20 |
| — | UBS | Buy | — | — | Reiterated | 2025-11-06 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-11-06 |
| — | TD Cowen | Buy | — | — | Reiterated | 2025-10-14 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-10-07 |
| — | RBC Capital | Outperform | — | — | Upgraded | 2025-09-03 |
| — | Citigroup | Buy | — | — | Upgraded | 2025-08-21 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2025-08-07 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-07-11 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-06-05 |
| — | UBS | Buy | — | — | Reiterated | 2025-05-09 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-05-08 |
| — | Stifel | Hold | — | — | Reiterated | 2025-05-08 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2025-05-08 |
| — | Keybanc | Sector Weight | — | — | Downgraded | 2025-04-09 |
| — | Keybanc | Sector Weight | — | — | Downgraded | 2025-04-08 |
| — | Citigroup | Neutral | — | — | Reiterated | 2025-03-04 |
| — | Baird | Neutral | — | — | Downgraded | 2025-02-19 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-02-06 |
| — | Baird | Outperform | — | — | Reiterated | 2025-02-06 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2025-02-06 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-02-06 |
| — | Baird | Outperform | — | — | Reiterated | 2024-10-31 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-10-31 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-08-13 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2024-08-08 |
| — | Baird | Outperform | — | — | Reiterated | 2024-08-08 |
| — | Citigroup | Neutral | — | — | Downgraded | 2024-05-22 |
| — | Baird | Outperform | — | — | Reiterated | 2024-05-02 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-05-02 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2024-04-18 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2024-02-02 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-02-02 |
| — | Stifel | Hold | — | — | Downgraded | 2024-02-02 |
| — | Stifel | Buy | — | — | Reiterated | 2023-11-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-11-01 |
| — | Keybanc | Overweight | — | — | Reiterated | 2023-11-01 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2023-11-01 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2023-09-12 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-08-18 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-08-09 |
TECH earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-04 | 0.43 | 0.46 | $290.5M | $295.9M |
| 2026-05-06 | 0.55 | 0.53 | $316.1M | $311.4M |
| 2026-08-12 | 0.52 | 0.52 | $314.6M | $321.2M |
| 2026-11-04 | 0.44 | 0.00 | $292.6M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.